Publication

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

This review explores how artificial intelligence (AI), machine learning (ML), and quantitative systems pharmacology (QSP)…

Certara2026 年 6 月 2 日

On-Demand Webinar

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…

Certara2026 年 5 月 26 日

Poster

Advancing In Vivo CAR-T with QSP

Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…

Certara2026 年 5 月 12 日

Video

Certara IQ™ Demo

Watch a short demo of Certara IQ™, a QSP platform for modeling, simulation, and analysis.…

Certara2026 年 5 月 12 日

Publication

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

QSP modeling reveals how anti-amyloid therapies impact tau biomarkers and cognitive outcomes in Alzheimer’s disease.

Certara2026 年 5 月 4 日

Poster

Modeling CAR-T Outcomes in Multiple Myeloma

Learn how QSP modeling predicts CAR-T therapy outcomes, identifies patient-specific response drivers, and supports multi-antigen…

Certara2026 年 5 月 4 日

Poster

Modeling T-cell Exhaustion in Immunotherapy

Discover how QSP modeling predicts T-cell exhaustion, relapse risk, and optimal dosing strategies for T-cell…

Certara2026 年 5 月 4 日

Poster

Modeling Hematopoiesis in MDS and AML with QSP

Discover a mechanistic QSP platform model of hematopoiesis to evaluate therapies in MDS and AML,…

Certara2026 年 5 月 1 日

Poster

IO Simulator: A QSP Platform for Immuno-Oncology

This poster showcases how IO Simulator predicts immunotherapy response and supports combination design and biomarker…

Certara2026 年 4 月 30 日

Blog

QSP at an Inflection Point: Scaling Impact

The QSP Summit at Certainty US 2026 brought together industry leaders to explore how Quantitative…

Certara2026 年 4 月 29 日

Certara Products – Certara IQ

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Advancing In Vivo CAR-T with QSP

Certara IQ™ Demo

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

Modeling CAR-T Outcomes in Multiple Myeloma

Modeling T-cell Exhaustion in Immunotherapy

Modeling Hematopoiesis in MDS and AML with QSP

IO Simulator: A QSP Platform for Immuno-Oncology

QSP at an Inflection Point: Scaling Impact

订阅时事通讯

快捷链接

解决方案

联系我们